OS9 and glioma: Thus, in the PTEN-mut glioma, CLCF1, AEBP1, and OS9, which are significantly associated with survival time, may induce glioma progression and are critical targets for diagnosis, prognosis prediction, and treatment, giving therapeutic recommendations to glioma with mutant PTEN.